ADAGIO THERAPEUTICS, INC.

(ADGI)
  Rapport
Vertraagde tijd Nasdaq  -  22:00 06-07-2022
3.780 USD   +12.17%
05/07SECTOR UPDATE : Aandelen in de gezondheidszorg worstelen dinsdag
MT
05/07SECTOR UPDATE : Aandelen in de gezondheidszorg trekken zich terug in de dinsdaghandel
MT
05/07SECTOR UPDATE : Gezondheidszorg
MT
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproducten 
OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws in andere talen op ADAGIO THERAPEUTICS, INC.
05/07ADAGIO THERAPEUTICS : Announces Results of Annual Meeting of Stockholders and Evolution of..
05/07ADAGIO THERAPEUTICS, INC. : Change in Directors or Principal Officers, Other Events, Finan..
05/07SECTOR UPDATE : Health Care Stocks Struggle Tuesday
05/07SECTOR UPDATE : Health Care Stocks Retreating in Tuesday Trade
05/07SECTOR UPDATE : Health Care
05/07Adagio Therapeutics Appoints David Hering Permanent CEO and Director
05/07Mithril Capital's Ajay Royan Sends Letter Thanking Adagio Therapeutics Shareholders for..
05/07Adagio Announces David Hering Named Permanent Chief Executive Officer and Director
05/07Adagio Therapeutics, Inc. Appoints David Hering Permanent Chief Executive Officer
05/07Adagio Therapeutics, Inc. Appoints David Hering as Director
01/07Adagio Announces Results of Annual Meeting of Stockholders and Evolution of the Board o..
01/07Adagio Announces Results of Annual Meeting of Stockholders and Evolution of the Board o..
30/06ADAGIO THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
30/06Howard Mayer, M.D. Notifies Adagio Therapeutics, Inc. of His Decision to Resign from th..
24/06ADAGIO THERAPEUTICS, INC.(NASDAQGM : ADGI) dropped from Russell 2500 Growth Index
24/06ADAGIO THERAPEUTICS, INC.(NASDAQGM : ADGI) added to Russell Microcap Index
24/06ADAGIO THERAPEUTICS, INC.(NASDAQGM : ADGI) dropped from Russell 2000 Growth Index
24/06ADAGIO THERAPEUTICS, INC.(NASDAQGM : ADGI) added to Russell Microcap Value Index
24/06ADAGIO THERAPEUTICS, INC.(NASDAQGM : ADGI) dropped from Russell Small Cap Comp Growth Inde..
24/06ADAGIO THERAPEUTICS, INC.(NASDAQGM : ADGI) dropped from Russell 3000 Growth Index
24/06ADAGIO THERAPEUTICS, INC.(NASDAQGM : ADGI) added to Russell 3000E Index
24/06ADAGIO THERAPEUTICS, INC.(NASDAQGM : ADGI) dropped from Russell 3000E Growth Index
24/06ADAGIO THERAPEUTICS, INC.(NASDAQGM : ADGI) added to Russell 3000E Value Index
22/06ADAGIO THERAPEUTICS, INC. : Submission of Matters to a Vote of Security Holders (form 8-K)
22/06Declaration of Voting Results by Adagio Therapeutics, Inc
22/06Adagio Therapeutics, Inc. Elects Class I Directors
21/06Adagio Therapeutics, Inc. Announces Resignation of Anand Shah from the Board of Directo..
21/06ADAGIO THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
13/06ADAGIO THERAPEUTICS : Results from the Phase 2/3 Randomized, Double-Blind, Placebo-Control..
13/06ADAGIO THERAPEUTICS : ADG20, a half-life–extended monoclonal antibody in development..
06/06Mithril Capital Management LLC Solicits Proxies from Shareholders of Adagio Therapeutic..
19/05ADAGIO THERAPEUTICS : Material Event - Form 8-K
19/05ADAGIO THERAPEUTICS, INC. : Other Events (form 8-K)
19/05Adagio Therapeutics Provides Information to Shareholders
13/05ADAGIO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition ..
13/05Adagio Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31..
13/05Adagio Therapeutics Reports Q1 Loss, Higher Operating Expenses
13/05Adagio Therapeutics Reports First Quarter 2022 Financial Results
26/04Adagio Therapeutics Inc Solicits Proxies from Shareholders
25/04Mithril Capital Provides Information to Shareholders of Adagio Therapeutics
14/04Adagio Therapeutics Pauses EUA Request for COVID-19 Drug Candidate Adintrevimab; Shares..
14/04Adagio Therapeutics Provides Update on Timing of Adintrevimab EUA Request
14/04Adagio Therapeutics, Inc. Provides Update on Timing of Adintrevimab EUA Request
11/04Mithril Capital Management LLC Solicits Proxies from Shareholders of Adagio Therapeutic..
31/03Adagio Therapeutics annonce que l'ADG20 (adintrevimab) est le premier anticorps monoclo..
31/03Adagio Therapeutics anuncia que ADG20 (adintrevimab) es el primer anticuerpo monoclonal..
31/03Adagio Therapeutics gibt bekannt, dass ADG20 (Adintrevimab) der erste monoklonale Antik..
31/03Adagio Therapeutics anuncia que ADG20 (adintrevimab) es el primer anticuerpo monoclonal..
31/03ADAGIO THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition ..
31/03NORTH AMERICAN MORNING BRIEFING : Stock Futures -3-
30/03Mithril Capital Nominates Candidates to the Board of Adagio Therapeutics
30/03SECTOR UPDATE : Health Care Stocks Close Slightly Lower
30/03SECTOR UPDATE : Health Care Stocks Still Trying to Find Direction
30/03Top Midday Gainers
30/03Wall Street Set for Downbeat Session, US Q4 GDP Growth Revised Down to 6.9%
30/03SECTOR UPDATE : Health Care Stocks Lean Lower Pre-Bell Wednesday
30/03Thiel-backed venture firm Mithril seeks to nominate candidates for Adagio's board
30/03SECTOR UPDATE : Health Care
30/03ADAGIO THERAPEUTICS : Announces ADG20 (adintrevimab) is the First Monoclonal Antibody to M..
30/03Top Premarket Gainers
30/03Adagio Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31,..
30/03Mithril Capital Management Communicates with Adagio Therapeutics
30/03Adagio Therapeuticsts Meets Primay Endpoints in Phase2/3 Studies for Treatment of COVID..
30/03Adagio Therapeutics Announces ADG20 (adintrevimab) is the First Monoclonal Antibody to ..
30/03Adagio Therapeutics Announces ADG20 (adintrevimab) is the First Monoclonal Antibody to ..
21/03ADAGIO THERAPEUTICS : AMENDED AND RESTATED EMPLOYMENT AGREEMENT - Form 8-K
21/03ADAGIO THERAPEUTICS : AMENDED AND RESTATED EMPLOYMENT AGREEMENT - Form 8-K/A
21/03ADAGIO THERAPEUTICS, INC. : Change in Directors or Principal Officers, Other Events, Finan..
21/03ADAGIO THERAPEUTICS, INC. Change in Directors or Principal Officers, Financial Stateme..
21/03Adagio Therapeutics, Inc. Appoints Jane Pritchett Henderson as Chief Business Officer
21/03ADAGIO THERAPEUTICS, INC.(NASDAQGM : ADGI) dropped from S&P Biotechnology Select Industry ..
18/03Adagio Therapeutics, Inc. Announces 2022 Annual Meeting of Stockholders
18/03Adagio Therapeutics, Inc. Announces 2022 Annual Meeting of Stockholders
01/03ADAGIO THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
01/03Adagio Therapeutics, Inc. Announces Executive Changes, Effective March 25, 2022
1  2  3Volgende